Royalty Pharma
40.18
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Royalty Pharma
Royalty Pharma plc是生物制药特许权使用费的最大买家，也是生物制药行业创新的主要资助者。自1996年成立以来，一直是特许权使用费市场的先驱，与来自学术机构和非营利组织的创新者（通过中小型生物技术公司到全球领先的制药公司）合作。
Trade GPT
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.